← Back to Clinical Trials
Recruiting NCT06172842

NCT06172842 Multi-modality Echocardiography for Cardiac Assessment in Primary Electrical Disease

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06172842
Status Recruiting
Phase
Sponsor Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Condition Multi-modality Echocardiography
Study Type OBSERVATIONAL
Enrollment 30 participants
Start Date 2024-01
Primary Completion 2025-12

Eligibility & Interventions

Sex All sexes
Min Age N/A
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Echocardiography

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 30 participants in total. It began in 2024-01 with a primary completion date of 2025-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

From 2020 to 2023, patients with primary electrical disease (idiopathic ventricular fibrillation, long QT syndrome, Andersen-Tawil syndrome type I, Brugada syndrome, early repolarization syndrome, CPVT, and short QT syndrome) were first diagnosed at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, and clinical data and echocardiographic indicators were recorded. Follow-up is until December 30, 2025 or endpoint event occurs. Endpoint events were defined as sustained ventricular tachycardia, ventricular fibrillation, sudden cardiac death, ICD discharge events, all-cause death, heart failure and heart transplantation, which were statistically analyzed as a composite endpoint of cardiovascular analysis. The predictors of primary electrical disease and the risk factors for adverse cardiovascular events were analyzed.

Eligibility Criteria

Inclusion Criteria: * primary electrical disease Exclusion Criteria: * Congenital heart disease, poor echocardiographic images, moderate or severe valvular disease

Contact & Investigator

Central Contact

hanlu lv

✉ lv-hl@163.com

📞 13430268178

Frequently Asked Questions

Who can join the NCT06172842 clinical trial?

This trial is open to participants of all sexes, studying Multi-modality Echocardiography. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06172842 currently recruiting?

Yes, NCT06172842 is actively recruiting participants. Contact the research team at lv-hl@163.com for enrollment information.

Where is the NCT06172842 trial being conducted?

This trial is being conducted at Guangzhou, China.

Who is sponsoring the NCT06172842 clinical trial?

NCT06172842 is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The trial plans to enroll 30 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology